ACUVUE™ RevitaLens Multi-Purpose Disinfecting Solution

acuvue revitalens final
For patients who require a contact lens care solution

Protection for your patients

  • Dual disinfection technology* provides broadspectrum disinfection against FDA/ISO standard panel micro-organisms, comparable to peroxide systems1,2,3
  • Provides sustained antimicrobial activity in the lens case—even after partial evaporation+3
  • Delivers exceptional disinfection against harmful germs and bacteria but is gentle on the eye7,8

Provides all-day comfort for your patients9

  • 90% of patients agree that ACUVUE™ RevitaLens MPDS was effective in keeping their contact lenses feeling comfortable^1
  • Nearly 94% of patients found ACUVUE™ RevitaLens MPDS effective in keeping their contact lenses feeling clean^10

A tried and tested combination you and your patients can rely on6

In clinical studies, the combination of ACUVUE™ RevitaLens MPDS and ACUVUE® Brand Contact Lenses resulted in:

  • All-day comfort10
  • Healthy ocular physiology10

What your patients want to know about ACUVUE™ RevitaLens Multi-Purpose Disinfecting Solution

  1. Disinfects like a peroxide1,2,3 with the simplicity and all-day comfort of an advanced multi-purpose solution
  2. Kills greater than 99.9% of bacteria9,11
  3. Lens comfort that lasts all day9
  4. A Great Match with ACUVUE® contact lenses and other leading brands9

Product Specifications

Lens material

Lens design

Water content

Base curve

Diameter

Power range

Centre thickness

Oxygen transmissibility (Dk/t)(boundary and edge corrected)

Oxygen flux (% available to cornea)
Oxygen transmissibility (Dk/t)(boundary and edge corrected)†

Class 2 UV Blocking

Visibility features

Recommended replacement schedule

image igro

* Defined as Alexidine dihydrochloride (0.00016%) ALX (which is a biguanide molecule smaller and more hydrophobic than polyhexamethylene biguanide (PHMB)) and Polyquaternium-1 (0.0003%) PQ-1. + 6 multi-purpose solutions tested in study. Results present for solutions that are still commercially available ^ Multicenter, open-label study in Europe and USA (n=2,979). 1. Heaselgrave W, Kilvington S, Lonnen J. Efficacy of contact lens care solutions against clinical microorganisms [Abstract 56]. In: Abstracts of the 2011 BCLA Annual Clinical Conference. Manchester, UK; 2011:34(1); S30. 2. Nikolic M, Kilvington S, Brady N, et al. Comparative efficacy of new contact lens care solutions against bacteria, fungi and Acanthamoeba [abstract 59]. In: Abstracts of the 2011 BCLA Annual Clinical Conference. Manchester, UK; 2011:34(1); S31. 3. Kilvington S, Powell CH, Lam A, et al. Antimicrobial efficacy of multi-purpose contact lens disinfectant solutions following evaporation. Cont Lens Anterior Eye 2011;34(4):183-187. 4. JJV data on file 2017. Multi-center 1-month dispensing daily wear study with senofilcon C toric CLs with RevitaLens OcuTec MPDS, worn for 30 days. N=130 habitual soft toric CL wearers in US. 5. Berntsen DA, Hickson-Curran SB, Jones LW, et al. Subjective Comfort and Physiology with Modern Contact Lens Care Products. Optom Vis Sci. 2016;93(8):809-819. 6. JJV Data on File 2018. Blink® RevitaLens MPDS Compatibility & Clinical Performance with Reusable ACUVUE® Brand Contact Lenses. 7. Tarantino N, Kao E, Huang L, et al. A clinical safety and acceptability evaluation of a novel multi-purpose disinfecting solution [abstract 60]. In: Abstracts of the 34th BCLA Annual Clinical Conference, Birmingham, 2010. Contact Lens Anterior Eye. 2010;33(6):256-300. doi: 10.1016/j.clae.2010.07.002. 8. Tilia D, Lazon de la Jara P, Weng R, et al. Clinical evaluation of a new contact lens solution when used in conjunction with two silicone hydrogel lenses during short term wear [abstract 31]. In: Abstracts of the 34th BCLA Annual Clinical Conference, Birmingham, 2010.Contact Lens Anterior Eye. 2010;33(6):256-300. doi: 10.1016/j.clae.2010.07.002. 9. JJV Data on File 2018. ACUVUE™ RevitaLens Multipurpose Disinfecting Solution Packaging Claims. 10. Owen JP. Global RevitaLens Experience and Acceptance Trial (GREAT Trial) [abstract 4720]. In: Association for Research in Vision and Ophthalmology. Invest. Ophthalmol. Vis. Sci. 2012;53(14):13-6954. 11. JJV Data on File 2009. In Vitro Evaluation of Antimicrobial Efficacy of ACUVUE RevitaLens Multipurpose Solution.

Skip to content